– Revenue increased 36% year over year to $10.3 million – Orders increased 65% year over year – Net income $2.2 million; Diluted EPS $0.06 – Adjusted EBITDA $2.8M – Twelfth consecutive quarter of positive net income ENGLEWOOD, Colo., July 31, 2019 /PRNewswire/ — Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing […]
Other News
Adagio Medical Treats First Persistent Atrial Fibrillation Patient With One Shot+™ Cryoablation Catheter Utilizing Only Anatomical Markers For Accurate Imaging
LAGUNA HILLS, Calif., July 31, 2019 /PRNewswire/ — Adagio Medical, Inc., the developer of iCLAS™, the company’s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces that the first PsAF patient was successfully treated with its new One Shot+™ cryoablation catheter in a procedure that utilizes only anatomical markers with limited usage […]
Abiomed Announces Q1 FY 2020 Revenue of $208 Million and 29.2% Operating Margin
DANVERS, Mass.–(BUSINESS WIRE)–Abiomed, Inc. (NASDAQ: ABMD), a leading provider of breakthrough heart recovery and support technologies, today reported first quarter fiscal 2020 revenue of $207.7 million, an increase of 15.4% compared to revenue of $180.0 million for the same period of fiscal 2019. Operating income was $60.7 million, up 30%, compared […]
AtriCure Reports Second Quarter 2019 Financial Results
Worldwide revenue of $58.9 million – an increase of 13.7% year over year U.S. revenue of $47.2 million – an increase of 15.5% year over year International revenue of $11.7 million – an increase of 7.0% year over year July 30, 2019 04:02 PM Eastern Daylight Time MASON, Ohio–(BUSINESS WIRE)–AtriCure, […]
Canon Medical Showcased the Alphenix Platform at Premier Inc.’s Annual Breakthroughs Conference
TUSTIN, Calif.–(BUSINESS WIRE)–The Alphenix™ platform is one of the medical innovations that was showcased in front of thousands of healthcare providers at Premier Inc.’s 2019 Breakthroughs Conference and Exhibition on June 18. Canon Medical’s Alphenix family of interventional systems was debuted during the conference’s 11th annual Innovation Celebration, an event recognizing advancements in healthcare and highlighting suppliers […]
PhysIQ Inc. Receives FDA Clearance of Continuous Ambulatory Respiration Rate Algorithm Enabling Artificial Intelligence-based Analytics for Biopharma Companies and Payers
FDA 510(k) cleared Respiration Rate analytic adds to physIQ’s growing portfolio of FDA 510(k) algorithms Clearance allows physIQ to power its higher-level AI analytics with validated vital sign inputs PhysIQ’s cloud-based analytics provide flexibility to biopharma companies and payers looking for consistent output while deploying a variety of devices across […]
LivaNova Reports Second Quarter 2019 Results
LONDON–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, today reported results for the quarter ended June 30, 2019. For the second quarter of 2019, worldwide sales from continuing operations were $277.2 million, a decrease of 3.6 percent on a reported basis and a decrease of 1.0 percent […]
BioTelemetry, Inc. Reports Second Quarter 2019 Financial Resu
July 30, 2019 16:05 ET | Source: BioTelemetry, Inc. Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today reported […]
Sensyne Health Signs Collaboration Agreement with Bayer to Accelerate the Development of New Treatments for Cardiovascular Disease using Clinical Artificial Intelligence
The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain. Sensyne Health […]
Prix Galien Selects BIOTRONIK’s PK Papyrus Covered Coronary Stent as Award Finalist
LAKE OSWEGO, Ore., July 31, 2019 /PRNewswire/ — BIOTRONIK today announced the company’s PK Papyrus® covered coronary stent system1 has been named a finalist in the 2019 Prix Galien USA Awards Ceremony for Best Medical Technology. PK Papyrus is used in emergency situations to create a physical barrier to seal life-threatening perforated coronary arteries without the need for invasive surgery. In September […]



